MOUNJARO
NDC 50090-8022 · A-S Medication Solutions
Generic nametirzepatide
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TIRZEPATIDE
Strength12.5 mg/.5mL
Pharmacologic classG-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
Marketing categoryNDA
Packages
50090-8022-0 — 4 SYRINGE in 1 CARTON (50090-8022-0) / .5 mL in 1 SYRINGE
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0002-3544 — tirzepatide, 0002-3555 — tirzepatide, 0002-3566 — tirzepatide, 0002-4052 — tirzepatide, 0002-4103 — tirzepatide, 0002-4210 — tirzepatide, 0002-4304 — tirzepatide, 0002-4523 — tirzepatide, 0002-4612 — tirzepatide, 0002-6052 — tirzepatide, 0002-6103 — tirzepatide, 0002-6210 — tirzepatide, 0002-6304 — tirzepatide, 0002-6523 — tirzepatide, 0002-6612 — tirzepatide, 50090-8021 — tirzepatide, 50090-8023 — tirzepatide, 50090-8024 — tirzepatide, 50090-8025 — tirzepatide, 50090-8026 — tirzepatide, +33 more